7 completed, 4 active not recruiting, 3 recruiting, 2 terminated. 6 Phase 1, 5 Not applicable, 3 Phase 2, 2 Phase 4.
Follow Human Papillomavirus-Related Carcinoma: new trials by email Literature Review of Human Papillomavirus-Related Carcinoma trials Research Report on Human Papillomavirus-Related Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men Cytology Specimen Collection Procedure, High Resolution Anoscopy with Biopsy, Laboratory Biomarker Analysis - HIV Infection, Human Papillomavirus Infection | Withdrawn | AIDS Malignancy Consortium | 2027-04-30 | 2025-06-06 | ||
| Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial Best Practice, Educational Intervention, Interview - Human Papillomavirus-Related Carcinoma | Not applicable | Recruiting | Fred Hutchinson Cancer Center | 1900 | 2026-10-15 | 2026-09-17 |
| Testing RG1-VLP Vaccine to Prevent HPV-related Cancers Biospecimen Collection, HPV16 RG1 VLP Vaccine, Questionnaire Administration - Human Papillomavirus-Related Carcinoma | Phase 1 | Recruiting | National Cancer Institute (NCI) | 18 | 2026-01-27 | 2026-09-09 |
| A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial Best Practice, Educational Intervention, Health Promotion and Education - Human Papillomavirus-Related Carcinoma | Not applicable | Recruiting | Emory University | 1836 | 2025-05-02 | 2026-09-03 |
| Clinical Decision Support Tools to Increase Human Papillomavirus (HPV) Vaccination in Adolescents in Pharmacies Discussion, Educational Activity, Healthcare Activity - Human Papillomavirus-Related Carcinoma | Not applicable | Terminated | Fred Hutchinson Cancer Center | 31 | 2024-02-28 | 2024-12-19 |
| Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcinoma Alpelisib, Carboplatin, Hyperpolarized Carbon-13 (13C) Pyruvate - Solid Tumors, Adult, PIK3CA Mutation-Related Tumors | Phase 1 | Withdrawn | Pamela Munster | 2022-11-01 | 2022-12-27 | |
| A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101, Pembrolizumab, Computed Tomography - Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma | Phase 1 / Phase 2 | Active not recruiting | Mayo Clinic | 20 | 2022-06-16 | 2026-10-07 |
| Human Papillomavirus Education Programs Educational Intervention, Informational Intervention, Survey Administration - Human Papillomavirus-Related Carcinoma | Not applicable | Completed | Ohio State University Comprehensive Cancer Center | 12 | 2022-04-27 | 2023-11-02 |
| HYHOPE: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer Hypofractionated intensity modulated radiotherapy - Human Papillomavirus-Related Carcinoma, Oropharyngeal Cancer | Phase 1 | Completed | University of Texas Southwestern Medical Center | 24 | 2020-12-03 | 2025-12-15 |
| HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults Educational Intervention, Survey Administration - Human Papillomavirus Infection, Human Papillomavirus-Related Carcinoma | Phase 4 | Completed | Mayo Clinic | 100 | 2020-10-19 | 2026-01-12 |
| Molecular Signatures of HPV+ ORL Cancers (OROPAP) Oropharyngeal Cancer, Human Papillomavirus-Related Carcinoma | Completed | Assistance Publique - Hôpitaux de Paris | 66 | 2019-06-01 | 2021-10-04 | |
| MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer Internal Radiation Therapy, Magnetic Resonance Imaging - Human Papillomavirus-Related Carcinoma, Human Papillomavirus-Related Cervical Carcinoma | Phase 1 | Terminated | M.D. Anderson Cancer Center | 26 | 2018-08-03 | 2026-09-15 |
| Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients Biospecimen Collection, HPV Self-Collection, Questionnaire Administration - Human Papillomavirus Infection, Human Papillomavirus-Related Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 51 | 2017-06-23 | 2026-09-14 |
| Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants Laboratory Biomarker Analysis, Recombinant Human Papillomavirus Nonavalent Vaccine - Human Papillomavirus-Related Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 201 | 2016-05-19 | 2026-07-10 |
| HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA HPV Specific T Cells, Cytoxan, Fludarabine - Human Papillomavirus-Related Carcinoma, Human Papillomavirus Positive Oropharyngeal Carcinoma | Phase 1 | Completed | Baylor College of Medicine | 35 | 2015-09-01 | 2026-10-02 |
| Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening HPV testing, Questionnaire Administration - Cervical Carcinoma, Human Papillomavirus-Related Carcinoma | Active not recruiting | University of California, San Francisco | 2556 | 2015-01-08 | 2026-05-04 | |
| Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients Quadravalent human papillomavirus vaccine - Late Complication From Kidney Transplant, Complication of Transplanted Liver | Phase 4 | Completed | The Hospital for Sick Children | 37 | 2013-10-01 | 2021-02-15 |
| MeFirst: A Tailored Intervention to HPV Vaccine Decision Making MeFirst Tailored Intervention - Human Papillomavirus-Related Carcinoma | Not applicable | Completed | University of Michigan | 661 | 2013-01-01 | 2015-07-22 |
Oropharyngeal Neoplasms (3) · Papillomavirus Infections (3) · Uterine Cervical Neoplasms (2) · Carcinoma (1) · HIV Infections (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Recurrence (1) · Vaginal Neoplasms (1)
Neoplasms (6) · Genital Diseases (5) · Neoplasms by Site (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Urogenital Diseases (5) · Disease Attributes (4) · Communicable Diseases (3) · DNA Virus Infections (3) · Head and Neck Neoplasms (3) · Infections (3) · Otorhinolaryngologic Diseases (3) · Otorhinolaryngologic Neoplasms (3) · Pharyngeal Diseases (3) · Pharyngeal Neoplasms (3)
Early Intervention, Educational (4) · Educational Status (4) · Methods (4) · Human Papillomavirus Recombinant Vaccine nonavalent (3) · Specimen Handling (3) · Biopsy (2) · Practice Guidelines as Topic (2) · Standard of Care (2) · Alpelisib (1) · Brachytherapy (1) · Carboplatin (1) · Cyclophosphamide (1) · Delivery of Health Care (1) · Health Promotion (1) · Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1)
National Cancer Institute (NCI) (3) · Fred Hutchinson Cancer Center (2) · Mayo Clinic (2) · AIDS Malignancy Consortium (1) · Assistance Publique - Hôpitaux de Paris (1) · Baylor College of Medicine (1) · Emory University (1) · M.D. Anderson Cancer Center (1) · Ohio State University Comprehensive Cancer Center (1) · Pamela Munster (1) · The Hospital for Sick Children (1) · University of California, San Francisco (1) · University of Michigan (1) · University of Texas Southwestern Medical Center (1)
United States (14) · Canada (1) · France (1) · India (1) · Uganda (1)
Ann H Klopp (1) · Carlos Ramos, MD (1) · David M. Routman, M.D. (1) · Dominic Moon, MD (1) · Electra D Paskett, PhD (1) · Gerardo Colon-Otero, M.D. (1) · Helen Heslop, MD (1) · Jeffrey Martin, MD, MPH (1) · Joel Palefsky (1) · Marc T Goodman (1) · Pamela Munster, MD (1) · Parth Shah (1) · Parth Shah, PharmD, PhD (1)
N01CN00031 (1), N01CN00035 (1), P30CA014520 (1), P30CA016672 (1), P30CA023074 (1), P30CA060553 (1), P30CA138292 (1), R21CA167653 (1), R37CA234119 (1), U54CA190153 (1), U54CA254571 (1), UG1CA242635 (1), UM1CA121947 (1)